Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00268047 · ClinicalTrials.gov registry record
Pulmonary Resistance in Fontan Who Have Undergone Heart Transplantation
A clinical trial, sponsored by Children's Healthcare of Atlanta.
- Terminated
- Registry status
- 50
- Enrollment target
NCT00268047 is a clinical trial that was terminated before completion, run by Children's Healthcare of Atlanta. The registered enrollment target is 50 participants.
The verdict
NCT00268047 was terminated before completion, sponsored by Children's Healthcare of Atlanta.
- TERMINATED
- Registry status
- 50 participants
- Enrollment target
Study Summary
Clinical evidence reveals that some patients who undergo cardiac transplantation exhibit problems with pulmonary vascular resistance as well. In some studies, an increase in pulmonary vascular resistance has been used as an indicator for increased 3-day and 3-month mortality after heart transplantation2. In this study, the investigators would like to look at pulmonary vascular resistance in patients with a surgical history of the Fontan procedure followed by heart transplantation.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 50 participants |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00268047
The ClinicalTrials.gov registry entry for NCT00268047 describes a study currently listed as terminated, categorized as an unspecified phase. The registered enrollment target is 50 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Children's Healthcare of Atlanta, which has 80 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT00268047 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00268047 about?
NCT00268047 is a clinical study titled "Pulmonary Resistance in Fontan Who Have Undergone Heart Transplantation". Clinical evidence reveals that some patients who undergo cardiac transplantation exhibit problems with pulmonary vascular resistance as well. In some studies, an increase in pulmonary vascular resistance has been used as an indicator for increased 3-day and 3-month mortality after heart transplantat...
What is the current status of trial NCT00268047?
This trial is currently terminated. The enrollment target is 50 participants.
Who is sponsoring clinical trial NCT00268047?
This trial is sponsored by Children's Healthcare of Atlanta, which has 80 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.